Epitalon Peptide
Four residues with a famous backstory that belongs to a different substance. The cited longevity studies used epithalamin, a bovine pineal extract, and the FDA has said plainly they are not the same thing.
Choose your pack
For research use only. Not for human or veterinary use.
What Epitalon Peptide is
The plain-language version, first.
A synthetic tetrapeptide living off another substance's press clippings.
Epitalon is a synthetic tetrapeptide, Ala-Glu-Asp-Gly, with free base formula C14H22N4O9, molar mass 390.35 and CAS 307297-39-8, designed in the late 1980s at the St Petersburg Institute of Bioregulation and Gerontology. Reviewing it for the FDA Pharmacy Compounding Advisory Committee in July 2026, the agency stated that epitalon and epithalamin are different substances and that none of the 26 articles submitted by the nominators discussed the use of epitalon.
Every so often a compound's entire reputation turns out to be a citation error, and this is the shelf's clearest case.
Epitalon is four residues: Ala-Glu-Asp-Gly. Synthetic, defined, simple.
The famous longevity studies everyone cites were run on epithalamin, a crude extract of cow pineal gland. A soup, not a sequence.
The tetrapeptide was later proposed as the extract's active ingredient, which is a hypothesis, and the literature migrated the extract's results onto the synthetic as if the hypothesis were proven.
The FDA, reviewing the compound, said it plainly: they are not the same substance.
A four-residue molecule wearing a forty-year-old extract's biography. Sorting out which claims belong to which substance is the entire job of reading about it.
What is epitalon?
Mechanism studied, not outcome promised.
The supporting work is in vitro: human somatic cells showing telomerase activity and telomere elongation. The intermediate steps to a human effect have not been published.
The four residues were chosen from the amino acid composition of epithalamin, a bovine pineal extract, on the reasoning that a defined peptide might reproduce what the mixture did.
The telomerase story is the claim. The identity switch underneath is the problem.
The headline mechanism attached to this molecule is telomerase activation, which is exactly the kind of claim that deserves slow reading.
Telomeres cap your chromosomes, they shorten with cell division, and telomerase rebuilds them. The idea of switching that on is genuinely seductive.
The supporting work is thin, old, largely from the same circle that developed the compound, and partly on the extract rather than the peptide.
And there is a sharp edge nobody selling it mentions: cells that reactivate telomerase at will are how cancers achieve immortality. A true telomerase switch would be double-edged by definition.
Here's the honest part.
Either it does not meaningfully activate telomerase, in which case the pitch fails, or it does, in which case the safety question is enormous and unstudied. The marketing wants both halves and cannot have them.
The research so far for Epitalon Peptide
Where the evidence is thin, we say so.
One study: 75 healthy women, 40 randomised, sublingual spray at 0.5 milligrams daily for 20 days, measuring a urinary melatonin metabolite. Blinding not specified. Plus cell culture telomerase work.
The famous longevity data. 266 elderly subjects over six to eight years, and follow-ups out to fifteen years, all using the bovine pineal extract, all from one research group, never independently replicated.
FDA reviewed the compound for its July 2026 advisory committee. The nominators submitted 26 articles. FDA wrote that none of the articles submitted discussed the use of epitalon, that seven discussed epithalamin which it considers a different substance, and that its own literature search identified no clinical studies assessing the safety of epitalon in humans.
The famous studies used the extract. This is not the extract.
The file needs sorting into three piles before it means anything.
Pile one: epithalamin extract studies. Decades old, Russian, on a bovine gland soup. These are the famous longevity numbers.
Pile two: synthetic epitalon work. Much smaller, mostly cell and animal, same originating circle. Pile three: independent replication. Nearly empty.
The FDA reviewed it in 2026 terms for compounding purposes and was blunt about the identity mismatch and the evidence gap.
Nothing approved anywhere.
Four residues, one borrowed biography, and a regulator on record saying the citations point at a different substance. Read pile by pile or you are reading fiction.
Epitalon vial sizes and current stock are just below.
Epitalon Peptide specs
The chemistry, exactly as released.
Who studies Epitalon Peptide
Who tends to order this one, and why.
A research compound does not have one audience. It has a handful of rooms where the same question keeps coming up, and the question is a different question in each of them.
Telomere biology
Telomerase induction in human somatic cells in culture is the mechanism the interest rests on, and it is where essentially all the direct epitalon evidence sits.
Chronobiology
The one human study measured urinary 6-sulfatoxymelatonin in night shift workers with low melatonin, which is a legitimate circadian endpoint.
Gerontology
The epithalamin literature, twenty five years of it from one group, on mortality and melatonin rhythm in elderly subjects.
Regulatory reviewers
FDA assessed it in July 2026 and proposed not adding it to the 503A bulks list, citing poor characterisation and absent human safety data.
Sold for laboratory research only. This is not guidance for personal use, and nothing here is a recommendation.
Epitalon Peptide backstory
How it got here.
Soviet and then Russian peptide research pursued short regulatory peptides as drugs for decades, largely separately from Western pharmaceutical development. The St Petersburg Institute of Bioregulation and Gerontology under Vladimir Khavinson was the centre of it.
The method was consistent: take an animal tissue, extract a polypeptide fraction, use it clinically, then attempt to identify a short defined peptide within it that carries the activity. Thymalin came from thymus by the same route.
Epithalamin was the pineal extract. Epitalon is the four residue peptide designed from its composition.
The clinical work stayed with the extract. The synthetic peptide became the product that travelled internationally, and it carried the extract's reputation with it.
- 1
A Soviet research tradition
Decades of work on short regulatory peptides at the St Petersburg Institute of Bioregulation and Gerontology under Vladimir Khavinson, pursued separately from Western drug development.
- 2
Extract first, peptide second
Epithalamin, a bovine pineal polypeptide extract, carried the clinical work. Epitalon was then designed from its amino acid composition.
- 3
The peptide travelled, the data did not
The synthetic four residue version became the internationally sold product and inherited the extract reputation, without inheriting its clinical file.
Buying Epitalon Peptide in Canada
What ships, how fast, and the paperwork.
The hard part of buying research material is almost never the compound. It is the logistics. What leaves the building, how fast it moves, and what is in the box beside the vial. Here is ours, plainly.
Know which substance the study used
If a claim about life extension is attached to this compound, check whether the study used epitalon or epithalamin. FDA considers them different substances, and nearly all the longevity data is about the bovine extract, not the synthetic tetrapeptide.
Same day out of British Columbia
Our building, our cold packs, our people, and nothing sitting in a customs queue while you refresh a tracking page.
Then into the fridge
Keep it cold and keep it dark. Sealed and freeze-dried it handles a rough trip without ice. Once it lands, fridge.
Stuff people ask about Epitalon Peptide
If your question is not here, email us. Real human answers.
No, and FDA says so directly: FDA considers epitalon and epithalamin as different substances. Epithalamin is a bovine pineal gland extract, a polypeptide complex. Epitalon is a synthetic four amino acid peptide, Ala-Glu-Asp-Gly, designed from the extract amino acid composition. Nearly every longevity claim made for epitalon comes from human studies of epithalamin.
One that FDA could identify. Ivko and colleagues in 2021 studied 75 healthy women aged 40 to 50, mostly night shift workers, randomising 40 with low melatonin to placebo or a sublingual spray at 0.5 milligrams daily for 20 days, measuring urinary 6-sulfatoxymelatonin. The publication did not specify blinding. There are zero registered clinical trials of epitalon on ClinicalTrials.gov.
FDA reviewed it for the Pharmacy Compounding Advisory Committee in July 2026 and proposed not adding epitalon free base or epitalon acetate to the 503A bulks list, citing poor physicochemical characterisation, lack of human safety data, immunogenicity concerns and no evidence of effectiveness for the proposed use. Of the 26 articles the nominators submitted, FDA wrote that none discussed the use of epitalon.
The supporting evidence is cell culture. Human somatic cells in vitro have shown telomerase activity and telomere elongation with this peptide. That is a real in vitro finding. What has not been published is evidence that it reaches relevant cells at achievable doses in a person and does the same thing there.
Because independent replication is how a finding becomes established rather than reported. The epithalamin longevity literature, spanning 2003 to 2011 and including a fifteen year follow-up, is authored by Khavinson or Korkushko, published in Russian institutional journals, and has not been reproduced by any group outside that network. That is a description of the evidence base, not an accusation about it.
It is not named on the WADA 2026 Prohibited List, but section S0 captures any pharmacological substance with no current approval by any governmental regulatory health authority for human therapeutic use. Epitalon has no such approval anywhere, so S0 applies and it is prohibited at all times.
Good pairing options with Epitalon Peptide
What researchers stack alongside it.
Pairing is where research gets ahead of itself. These are the compounds researchers put in the same order as Epitalon Peptide, which is a statement about ordering habits, not about evidence. Two things in one cart have not been studied together unless somebody studied them together.
Without a zinc atom it is completely inert. Not less active. Inert. The metal is not a supporting player here, it is half the molecule's identity.
It has no sequence and no CAS number, because it is not a molecule. It is an extract of calf thymus, still in clinical use across Russia, and that combination is genuinely unusual.
Order Epitalon Peptide right now
One last look before you decide.
Freeze-dried, COA on the page, ships cold
If you are researching Epitalon Peptide and you want a source you do not have to second-guess, start with the paperwork on this page. For research use only.
Not for human consumption. Not approved by Health Canada or any other regulatory body.
Page last updated August 19, 2026
People also search for Epitalon Peptide
Other names for the same compound.